8IU1
| Crystal structure of mouse Galectin-3 in complex with small molecule inhibitor | 分子名称: | 2-[(2R,3R,4S,5R,6R)-2-(3,4-dichlorophenyl)sulfanyl-6-(hydroxymethyl)-5-oxidanyl-4-[4-[3,4,5-tris(fluoranyl)phenyl]-1,2,3-triazol-1-yl]oxan-3-yl]oxyethanoic acid, Galectin-3, MAGNESIUM ION | 著者 | Jinal, S, Amit, K, Ghosh, K. | 登録日 | 2023-03-23 | 公開日 | 2024-03-27 | 実験手法 | X-RAY DIFFRACTION (1.97 Å) | 主引用文献 | Discovery and Exploration of Monosaccharide Linked Dimers to Target Fibrosis To Be Published
|
|
8ITZ
| Crystal structure of human Galectin-3 in complex with small molecule inhibitor | 分子名称: | 2-[(2R,3R,4S,5R,6R)-2-(3,4-dichlorophenyl)sulfanyl-6-(hydroxymethyl)-5-oxidanyl-4-[4-[3,4,5-tris(fluoranyl)phenyl]-1,2,3-triazol-1-yl]oxan-3-yl]oxyethanoic acid, CHLORIDE ION, Galectin-3, ... | 著者 | Jinal, S, Amit, K, Ghosh, K. | 登録日 | 2023-03-23 | 公開日 | 2024-03-27 | 実験手法 | X-RAY DIFFRACTION (1.22 Å) | 主引用文献 | Discovery and Exploration of Monosaccharide Linked Dimers to Target Fibrosis To Be Published
|
|
8ITX
| Crystal structure of human Galectin-3 in complex with small molecule inhibitor | 分子名称: | 2-[(2S,3R,4S,5R,6R)-2-[2-[2,5-bis(chloranyl)phenyl]-5-methyl-1,2,4-triazol-3-yl]-4-[4-[4-chloranyl-3,5-bis(fluoranyl)phenyl]-1,2,3-triazol-1-yl]-6-(hydroxymethyl)-5-oxidanyl-oxan-3-yl]oxyethanoic acid, CHLORIDE ION, Galectin-3, ... | 著者 | Jinal, S, Ghosh, K. | 登録日 | 2023-03-23 | 公開日 | 2024-03-27 | 実験手法 | X-RAY DIFFRACTION (1.12 Å) | 主引用文献 | Discovery and Exploration of Monosaccharide Linked Dimers to Target Fibrosis To Be Published
|
|
8ILU
| Crystal structure of mouse Galectin-3 in complex with small molecule inhibitor | 分子名称: | (2R,3R,4R,5R,6S)-2-(hydroxymethyl)-6-[2-(2-methyl-1,3-benzothiazol-6-yl)-1,2,4-triazol-3-yl]-4-[4-[3,4,5-tris(fluoranyl)phenyl]-1,2,3-triazol-1-yl]oxane-3,5-diol, Galectin-3, SODIUM ION, ... | 著者 | Kumar, A, Jinal, S, Raman, S, Ghosh, K. | 登録日 | 2023-03-04 | 公開日 | 2024-03-06 | 最終更新日 | 2024-09-25 | 実験手法 | X-RAY DIFFRACTION (1.8 Å) | 主引用文献 | Identification of benzothiazole derived monosaccharides as potent, selective, and orally bioavailable inhibitors of human and mouse galectin-3; a rare example of using a S···O binding interaction for drug design. Bioorg.Med.Chem., 101, 2024
|
|